• 2014

Company Description

Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.

Biohaven is a privately-held biopharmaceutical company engaged in the identification and development of clinical stage compounds targeting orphan neurologic indications and other neurological pathways.